Advertisement Pharmaceutical Business review - Page 4 of 4942 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 18, 2019

Acrotech to buy seven hematology/oncology products from Spectrum

Aurobindo Pharma’s subsidiary Acrotech Biopharma has agreed to acquire seven FDA-approved hematology/oncology products from Spectrum Pharmaceuticals in a deal valued at around $300m.

Image: Acrotech to acquire seven hematology/oncology products from Spectrum. Photo: courtesy of Sharon McCutcheon / Unsplash.